Eger, Hungary

Zoltán Katona



Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Egor, HU (2010)
  • Eger, HU (2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zoltán Katona: Innovator in Pharmaceutical Chemistry

Introduction

Zoltán Katona is a notable inventor based in Eger, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on the development of important pharmaceutical intermediates.

Latest Patents

One of his latest patents involves the preparation of 2-chloroethoxy-acetic acid-N,N-dimethylamide. This compound is synthesized by reacting 2-hydroxyethoxy-acetic acid-N,N-dimethylamide with thionyl chloride in a solvent, optionally in the presence of a catalyst, followed by solvent removal through distillation. Another significant patent relates to optically active carbamates, specifically 1-[(4-chlorophenyl)-phenylmethyl]-4-(2,2,2-trichloroethoxycarbonyl)-piperazine. This invention details the process for preparing this compound and its use as an intermediate in the synthesis of non-sedating antihistamine-type active pharmaceutical ingredients.

Career Highlights

Zoltán Katona has worked with prominent companies in the pharmaceutical industry, including Egis Gyógyszergyár Nyilvánosan Müködõ Részvénytársaság. His expertise in pharmaceutical chemistry has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

Throughout his career, Zoltán has collaborated with notable colleagues such as Tibor Mezei and Péter Trinka. These partnerships have fostered a collaborative environment that enhances innovation in their field.

Conclusion

Zoltán Katona's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of important pharmaceutical intermediates.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…